资源描述:
《长疗程吲哚美辛治疗极低出生体重儿动脉导管开放的疗效论文》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、长疗程吲哚美辛治疗极低出生体重儿动脉导管开放的疗效论文【摘要】目的:探讨延长吲哚美辛疗程治疗开放性动脉导管(PDA)的疗效和安全性。方法:46例合并PDA早产儿病例随机分为吲哚美辛治疗组24例和布洛芬治疗组22例。吲哚美辛组每次口服吲哚美辛0.2mg/kg,1次/12h,第3次服药后4~12h复查心脏彩色多普勒,PDA关闭者不再服药,未关闭者继续按原剂量服药两次,间隔时间相同,第5次服药后4~12h再次复查心脏彩色多普勒。布洛芬组首次给予10mg/kg,第2、第3次分别为5mg/kg.freelineethacintreatment
2、courseisefficaciousandsafeinclosureofpatentductusarteriosus(PDA)inveryloatureinfantsedbyechocardiographyallthan35ethacin(indomethacingroup),anothergroupinfantsethacingroupinfants,treatmentethacin0.2mg/kgbodyedoseat12hoursintervals.Thenechocardiographyedat4~12hoursafter
3、thethirdtimetakingdrug.IfitentedosesedagaintoconfirmifPDAcloseordonot.Intheibuprofengroupinfants,allbabyreceivedoralibuprofensuspension10mg/kgbodyg/kgeach.EchocardiographyedtodetermineifPDAcloseordonotat4~12hours32~36hoursafterthethirdtimetakingdrug.Serumsodium,serumcr
4、eatinine,plateletcount,serumbilirubineasuredandurineoutputentcourse.Results:Theclosurerateafterthefifthtimetakingmedicineedicine(95.83%vs62.50%,P0.05)inindomethacingroup.Thereethacinandibuprofenethacingroupthanthatinibuprofengroup(95.83%vs68.18%,P0.05).Casesnumbereithe
5、rserumsodiumlomol/LorurineoutputloL/(kg·h)inindomethacingroupberbilirubinreachtophototherapycriteriainibuprofengroupethacingroup(P0.05).Eithergroupnocasesdevelopintestinalperforationornecrotizingenterocolitis.Conclusions:Prolongedoralindomethacincourseiseffectiveandsaf
6、einVLBoragI,BatashD,etal.ClosureofpatentductusarteriosusatureneeireB,SmetsK,LecoutereD,etal.Aparisonofibuprofenandindomethacinforclosureofpatentductusarteriosus[J].NEnglJMed,2000,343:674681.[5]朴锦善,刁玉霞,苗树馨.口服美林治疗早产儿动脉导管未闭23例[J].中国新生儿科杂志,21:164165.[6]HerreraC,Holberton
7、J,DavisP.Prolongedversusshortcourseofindomethacinforthetreatmentofpatentductusarteriosusinpreterminfants[J].CochraneDatabaseSystRev,2004,1:CD003480.[7]BellanderM,LeyD,PolbergerS,etal.Tolerancetoearlyhumanmilkfeedingisnotpromisedbyindomethacininpreterminfantsethacininap
8、reterminfantptomaticpatentductusarteriosus[J].EurJPediatr,1990,149:651665.[9]NarayananM,SchlueterM,ClymanRI.Incidenc